We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Amgen and Astellas Pharma have agreed to pay nearly $125 million to settle federal allegations that they exploited charities to protect the prices of their favored drugs. Read More
In certain cases, the agency will request a comparison of the bispecific antibody to an approved monospecific product targeted against the same antigens. Read More
The authorities say Young prescribed 500,000 hydrocodone pills, 300,000 oxycodone pills, 1,500 fentanyl patches and more than 600,000 benzodiazepine pills in less than three years. Read More
The revised term would require a generic drug to contain the same active components in similar dosage forms as its Canadian reference product. Read More
The Canadian government on Wednesday announced a $60 million, seven-year plan to build a massive health database that backers hope will help the country come to grips with its opioid crisis. Read More
Drug sponsors can use complicated covariance analyses to help determine statistical significances or to help sharpen estimates of how well a treatment might work but they shouldn’t apply those analyses to anything in a clinical trial that might be affected by treatment, the FDA says in a new draft guidance document issued Wednesday. Read More
The Federal Trade Commission has filed a lawsuit against Surescripts, alleging that the e-prescription giant created and then ruthlessly protected a monopoly through loyalty provisions in contracts with drug suppliers and pharmacists. Read More
One of the nation’s ten largest drug distributors has agreed to pay $20 million as part of a consent decree with the federal government over felony criminal charges—the first ever targeting a distributor for illegal trafficking of controlled substances. Read More